Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $71.47 ($1.8M) on 2019-09-17, disclosed to the SEC on 2019-09-19.
Open-market sale of $1.8M GHDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-05-10 | $1.4M | — | Filing → |
| GHDX | SELL | 2019-02-01 | $3.7M | — | Filing → |